E-viri
Recenzirano
Odprti dostop
-
Geers, Daryl; Sablerolles, Roos S.G.; van Baarle, Debbie; Kootstra, Neeltje A.; Rietdijk, Wim J.R.; Schmitz, Katharina S.; Gommers, Lennert; Bogers, Susanne; Nieuwkoop, Nella J.; van Dijk, Laura L.A.; van Haren, Eva; Lafeber, Melvin; Dalm, Virgil A.S.H.; Goorhuis, Abraham; Postma, Douwe F.; Visser, Leo G.; Huckriede, Anke L.W.; Sette, Alessandro; Grifoni, Alba; de Swart, Rik L.; Koopmans, Marion P.G.; van der Kuy, P. Hugo M.; GeurtsvanKessel, Corine H.; de Vries, Rory D.
iScience, 01/2023, Letnik: 26, Številka: 1Journal Article
The emergence of novel SARS-CoV-2 variants led to the recommendation of booster vaccinations after Ad26.COV2.S priming. It was previously shown that heterologous booster vaccination induces high antibody levels, but how heterologous boosters affect other functional aspects of the immune response remained unknown. Here, we performed immunological profiling of Ad26.COV2.S-primed individuals before and after homologous or heterologous (mRNA-1273 or BNT162b2) booster. Booster vaccinations increased functional antibodies targeting ancestral SARS-CoV-2 and emerging variants. Especially heterologous booster vaccinations induced high levels of functional antibodies. In contrast, T-cell responses were similar in magnitude following homologous or heterologous booster vaccination and retained cross-reactivity towards variants. Booster vaccination led to a minimal expansion of SARS-CoV-2-specific T-cell clones and no increase in the breadth of the T-cell repertoire. In conclusion, we show that Ad26.COV2.S priming vaccination provided a solid immunological base for heterologous boosting, increasing humoral and cellular responses targeting emerging variants of concern. Display omitted •mRNA-based booster after Ad26.COV2.S priming induces strong immune responses•Booster vaccinations induce cross-reactive (non-)neutralizing antibodies•T cells after booster vaccination retain reactivity with novel variants of concern•Booster vaccinations do not increase the T-cell repertoire diversity Health sciences; Immunology; Immune response; Virology
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.